The results will need to confirmed in a much bigger clinicaltrial, the design of which Acorda will need to discuss with the Food and Drug Administration.
In order to design and run a successful clinicaltrial, it is crucial for the actual investigators to collect the data themselves and not rely on information gathered by other groups.
For the best outcome and restoration of trust, this completely independent group of researchers would analyze data (and preferably design) from an industry-linked clinicaltrial.